Related Experiment Video

Updated: Jun 11, 2025

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.7K

Position statement of Polish Cardiac Society experts on cardiomyopathy

Katarzyna Mizia-Stec1, Paweł Burchardt2,3, Łukasz Mazurkiewicz4

  • 11st Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.

Kardiologia Polska
|October 8, 2024
PubMed

Insights

Cardiomyopathies (CMs) are diverse heart muscle diseases requiring genetic and phenotypic evaluation for effective management. Early, multidisciplinary care models are crucial for improving patient outcomes and diagnosis, particularly in regions like Poland.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Cardiomyopathies (CMs) encompass a wide spectrum of genetic and acquired heart muscle diseases.
  • Classification relies on phenotypic characteristics, but identifying the underlying etiology, often genetic, is vital for clinical management.
  • Geographical and ethnic variations in genetic variant distribution necessitate localized data.

Purpose of the Study:

  • To review the classification, diagnosis, and management of cardiomyopathies.
  • To highlight the need for early detection and effective treatment strategies.
  • To propose the development of a diagnostic and therapeutic model for Polish patients based on European examples.

Main Methods:

  • Review of existing literature on cardiomyopathy classification and management.
  • Analysis of phenotypic characteristics and diagnostic approaches, including imaging and genetic testing.
  • Examination of systemic care models in European countries (France, Spain) for potential adaptation.

Main Results:

  • Cardiomyopathies present with diverse causes and phenotypes, impacting diagnosis and treatment.
  • Late diagnosis is common due to complex presentation and limited diagnostic test availability.
  • Multidisciplinary care structures are essential for optimizing patient management.

Conclusions:

  • Effective management of cardiomyopathies requires a personalized, expert, and coordinated approach.
  • Establishing multidisciplinary teams is crucial for improving patient care.
  • Adapting European care models could facilitate earlier detection and treatment of CMs in Poland.

Keywords:
Polish Cardiac Societycardiomyopathyposition of experts

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.1K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.7K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2